AUPH · Aurinia Pharmaceuticals Inc.
Market Cap
$2.14B
Shares
133.05M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1600620
CUSIP
05156V102
13F (30d)
175 filings
174 filers
Visit website
Investor relations